compositions and methods for reprogramming t-cell receptors using fusion proteins

• 收藏
• 分享

专利权人:

TCR2 THERAPEUTICS INC.

发明人:

GREGORY SIECZKIEWICZ,PATRICK BAEUERLE,ROBERT HOFMEISTER

申请号：

BR112019007100

公开号：

BR112019007100A2

申请日:

2017.10.06

申请国别(地区):

BR

年份:

2019

代理人:

摘要：

These are t-cell receptor (tcr) fusion proteins (tfps), t-cells genetically engineered to express one or more tfps, and methods of using them for treating diseases, including cancer.trata-se de proteínas de fusão (tfps) de receptor de célula t (tcr), células t geneticamente modificadas para expressar uma ou mais tfps e métodos de uso das mesmas para o tratamento de doenças, incluindo câncer.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/